Lumos Diagnostics Holdings LDX.AX · AUD

Its shares trade on ASX under the ticker LDX.AX. It has been listed since 5 July 2021. In the fiscal year to 30 June 2025, it reported revenue of $12.4m and a net loss of $7.2m. At that date it held total assets of $20.8m and shareholders' equity of $6.2m.

Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care (POC) diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2021-07-05. The firm offers customized assay development and manufacturing services for POC tests and digital reader platforms. The company also directly develops, manufactures, and commercializes, Lumos-branded POC tests that target infectious and inflammatory diseases. The Company’s products include FEBRIDX, COVIDX, and ViraDx. FebriDx is a point-of-care test which can be used to detect and aid in differentiating bacterial from viral acute respiratory infections. ViraDx is a point-of-care, three-in-one COVID-19/Flu A/Flu B rapid antigen test. Its services include assay development, reader development, cloud and data, and manufacturing. The company manages the full development program for point-of-care (POC) assays, from sourcing and/or generation of reagents, right through to verification and validation.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Samuel LanyonExecutive Chairman of the Board, since 2019$269,690
• Mr. Doug WardChief Executive Officer, Managing Director, Director, since 2022$15,900
• Mr. Lawrence MehrenNon-Executive Deputy Chairman of the Board$85,667
• Mr. Barrie LambertChief Financial Officer$83,681
• Mr. Paul KaseSenior Vice President of Commercial Operations
• MS. Sacha DopheideChief Technology Officer
• Mr. Kepa OyarbideVice President Technology Transfer and Pilot Manufacturing
• Ms. Annie BellSenior Director of Medical Affairs
• Ms. Sarah GlubkaSenior Director of Human Resources
• Ms. Sue HibbelnSenior Director of Regulatory Affairs
• Ms. Melanie LeydinCompany Secretary, since 2022
• Ms. Tracy WeimarCompany Secretary

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.